478 filings
Page 4 of 24
8-K
jjl9025h3b6a3lqp
14 Oct 22
NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing
4:20pm
8-K
n1m1h4k71opg 51
3 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:15am
8-K
9trsmi2m6q5f
12 Sep 22
Submission of Matters to a Vote of Security Holders
4:47pm
8-K
z0huusnx46qc5pmtu6x
11 Aug 22
NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022
8:05am
DEFA14A
213f7o31hqllm
22 Jul 22
Additional proxy soliciting materials
4:36pm
8-K
63k7m6od3s zz63g
29 Jun 22
NeuBase Therapeutics Announces Promotion of Dr. William Mann to President and COO
8:03am
8-K
e6jez2 2zgpelp30tyi
12 May 22
NeuBase Therapeutics Reports Business Update and Financial Results
5:01pm
S-8
974oox3
8 Apr 22
Registration of securities for employees
4:53pm
8-K
f19fl
14 Mar 22
Regulation FD Disclosure
6:07am
8-K
0er odcvn9
11 Feb 22
NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2022
12:00am
8-K
ksfohxt7 s3
10 Jan 22
NeuBase Therapeutics Appoints Todd P. Branning Chief Financial Officer
4:06pm
8-K
fmto5823
5 Jan 22
NeuBase Therapeutics Appoints Dr. Eric J. Ende to Board of Directors
4:03pm
8-K
5qbhjn3hbl2u8d4zi8
23 Dec 21
NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021
4:02pm
8-K
p8cw ssus
22 Oct 21
Departure of Directors or Certain Officers
4:17pm